- Home
- FRD vs LUCD Comparison
FRD vs LUCD Comparison
Compare FRD & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRD | LUCD |
|---|---|---|
| Founded | 1965 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.2M | 132.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | FRD | LUCD |
|---|---|---|
| Price | $20.40 | $1.18 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $3.94 |
| AVG Volume (30 Days) | 14.3K | ★ 2.5M |
| Earning Date | 02-06-2026 | 03-23-2026 |
| Dividend Yield | ★ 0.78% | N/A |
| EPS Growth | ★ 43.48 | N/A |
| EPS | ★ 1.63 | N/A |
| Revenue | ★ $510,450,000.00 | $4,399,000.00 |
| Revenue This Year | N/A | $7.69 |
| Revenue Next Year | N/A | $155.47 |
| P/E Ratio | $12.61 | ★ N/A |
| Revenue Growth | ★ 8.72 | 5.01 |
| 52 Week Low | $12.24 | $0.89 |
| 52 Week High | $23.50 | $1.80 |
Technical Indicators
Market Signals| Indicator | FRD | LUCD |
|---|---|---|
| Relative Strength Index (RSI) | 57.02 | 49.84 |
| Support Level | $18.25 | $1.11 |
| Resistance Level | $19.95 | $1.63 |
| Average True Range (ATR) | 0.82 | 0.12 |
| MACD | 0.17 | -0.00 |
| Stochastic Oscillator | 85.38 | 21.58 |
Price Performance
Historical ComparisonAbout FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.